NCT01815008View on ClinicalTrials.gov

Pharmacogenomics of Antiplatelet Response - I

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Platelet AggregationPlatelet TranscriptomeCoronary Artery Disease
Interventions
DRUG

Clopidogrel

Clopidogrel 75 mg daily

DRUG

Aspirin

Aspirin 81 mg daily

Trial Locations (1)

21287

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT01815008 - Pharmacogenomics of Antiplatelet Response - I | Biotech Hunter | Biotech Hunter